Revolade Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Description

Revolade 25 mg film-coated tablets: White, round, biconvex film-coated tablet (approximately 10.3 mm in diameter) debossed with 'GS NX3' and '25' on one side.
Each film-coated tablet contains eltrombopag olamine equivalent to 25 mg eltrombopag.
Revolade 50 mg film-coated tablets: Brown, round, biconvex film-coated tablet (approximately 10.3 mm in diameter) debossed with 'GS UFU' and '50' on one side.
Each film-coated tablet contains eltrombopag olamine equivalent to 50 mg eltrombopag.
Excipients/Inactive Ingredients: Revolade 25 mg film-coated tablets: Tablet core: Magnesium stearate, Mannitol, Microcrystalline cellulose, Povidone, Sodium starch glycolate.
Tablet coating: Hypromellose, Macrogol 400, Polysorbate 80, Titanium dioxide (E171).
Revolade 50 mg film-coated tablets: Tablet core: Magnesium stearate, Mannitol, Microcrystalline cellulose, Povidone, Sodium starch glycolate.
Tablet coating: Hypromellose, Iron oxide red (E172), Iron oxide yellow (E172), Macrogol 400, Titanium dioxide (E171).

Manufacturer:

Novartis

Distributor:

DKSH